Agency for Healthcare Research and Quality. HCUP Statistical Brief #133: Components of cost increases for inpatient hospital procedures, 1997–2009, http://www.hcup-us.ahrq.gov/reports/statbriefs/sb133.pdf (2012, accessed 29 August 2021).
TinegateHPendryKMurphyM, et al.Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014. Transfusion2016; 56: 139–145.
5.
RobichMPKochCGJohnstonDR, et al.Trends in blood utilization in United States cardiac surgical patients. Transfusion2015; 55: 805–814.
6.
Bennett-GuerreroEZhaoYO’BrienSM, et al.Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA2010; 304: 1568–1575.
7.
HorvathKAAckerMAChangH, et al.Blood transfusion and infection after cardiac surgery. Ann Thorac Surg2002; 74: 1180–1186.
BoerCMeestersMIMilojevicM, et al.2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth2018; 32: 88–120.
10.
TibiPMcClureRSHuangJ, et al.STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management. Ann Thorac Surg2021; 112: 981–1004.
11.
American Association of Blood Banks Standards Committee. Standards for a patient blood management program. 3rd ed. Bethesda: American Association of Blood Banks, 2020.
12.
MeybohmPWestphalSRavnHB, et al.Perioperative anemia management as part of PBM in cardiac surgery—a narrative updated review. J Cardiothorac Vasc Anesth2020; 34: 1060–1073.
13.
RaphaelJMazerDCSubramaniS, et al.Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for the management of perioperative bleeding and hemostasis in cardiac surgery patients. J Cardiothorac Vasc Anesth2019; 33: 2887–2899.
14.
RanucciMPavesiMPistuddiV, et al.Preoperative anemia correction in cardiac surgery: a propensity matched study. J Cardiothorac Vasc Anesth2021; 35: 874–881.
15.
PadmanabhanHSiauKCurtisJ, et al.Preoperative anemia and outcomes in cardiovascular surgery: systematic review and meta-analysis. Ann Thorac Surg2019; 108: 1840–1848.
16.
LaParDJHawkinsRBMcMurryTL, et al.Preoperative anemia versus blood transfusion: which is the culprit for worse outcomes in cardiac surgery?J Thorac Cardiovasc Surg2018; 156: 66–74.
17.
JabagiHBoodwaniMTranDT, et al.The effect of preoperative anemia on patients undergoing cardiac surgery: a propensity-matched analysis. Semin Thorac Surg2018; 31: 157–163.
18.
KochCGSesslerDIMaschaEJ, et al.A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg2017; 104: 1243–1250.
19.
LaParDJCrosbyIKAilawadiG, et al.Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg2013; 145: 796–804.
20.
PadmanabhanHBrookesMJNevillAM, et al.Association between anemia and blood transfusion with long-term mortality after cardiac surgery. Ann Thorac Surg2019; 108: 687–692.
21.
KeiTMistryNCurleyG, et al.Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anesth2019; 66: 716–731.
22.
WeltertLRondinelliBBelloR, et al.A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion2015; 55: 1644–1654.
23.
SpahnDRSchoenrathFSpahnGH, et al.Effect of ultra-short-term treatment of patients with iron deficiency or anemia undergoing cardiac surgery: a prospective randomized trial. Lancet2019; 393: 2201–2212.
24.
BlaudszunGButchartAKleinAA. Blood conservation in cardiac surgery. Transfus Med2018; 28: 168–180.
25.
SitkowskiDSzygulaZPokrywkaA, et al.Interrelationships between changes in erythropoietin, plasma volume, haemoglobin concentration, and total haemoglobin mass in endurance athletes. Res Sports Med2018; 26: 381–389.
26.
MenkisAHMartinJChengDCH, et al.Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations2012; 7: 229–241.
27.
RichardsTBaikadyRRClevengerB, et al.Preoperative intravenous iron to treat anemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet2020; 396: 1353–1361.
28.
XuHDuanYYuanX, et al.Intravenous iron versus placebo in the management of postoperative functional iron deficiency anemia in patients undergoing cardiac valve surgery: a prospective, single-blinded, randomized controlled trial. J Cardiothorac Vasc Anesth2019; 33: 2941–2948.
29.
CaoCIndraratnaPAngS, et al.Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis. J Thorac Cardiovasc Surg2014; 148: 3092–3098.
30.
NagashimaZTsukaharaKUchdaK, et al.Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting. J Cardiol2017; 69: 156–161.
31.
ZafarMUSmithDABaberU, et al.Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor. Circ Cardiovasc Interv2017; 10: e005120.
32.
AliJGerrardCClaytonJ, et al.Hemostasis checklist reduces bleeding and blood product consumption after cardiac surgery. Ann Thorac Surg2021; 111: 1570–1577.
33.
FazminITAliJ. Re-exploration and bleeding rates after cardiac surgery can be reduced-the utility of a checklist.J Card Surg2021; 36: 417–419.
34.
MylesPSSmithJAForbesA, et al.Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med2017; 376: 136–148.
35.
VonkABMeestersMIGarnierRP, et al.Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study. Transfusion2013; 53: 2782–2789.
36.
EngelsGEvan KlaenboschJGuYJ, et al.Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury. Interact Cardiovasc Thorac Surg2016; 22: 298–304.
37.
CarlessPAHenryDAMoxeyAJ, et al.Cell salvage for minimizing perioperative allogenic blood transfusion. Cochrane Database Syst Rev2010; 4: CD001888.
38.
ChandlerWL. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth2005; 19: 459–467.
39.
HensleyNBGyiRZorrilla-VacaA, et al.Retrograde autologous priming in cardiac surgery: results from a systematic review and meta-analysis. Anesth Analg2021; 132: 100–107.
40.
AdNHolmesSDPatelJ, et al.The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. J Thorac Cardiovasc Surg2017; 153: 597–605.
41.
TempeDKKhuranaP. Optimal blood transfusion practice in cardiac surgery. J Cardiothorac Vasc Anesth2018; 32: 2743–2745.
42.
BilecenSde GrootJAHKalkmanCJ, et al.Effectiveness of a cardiac surgery-specific transfusion protocol. Transfusion2014; 54: 708–716.
43.
MazerCDWhitlockRPFergussonDA, et al.Six month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med2018; 379: 1224–1233.
44.
HajjarLAVincentJLGalasFR, et al.Transfusion requirements after cardiac surgery. JAMA2010; 304: 1559–1567.
45.
ZeroualNBlinCSaourM, et al.Restrictive transfusion strategy after cardiac surgery: role of central venous oxygen saturation trigger: a randomized controlled trial. Anesthesiology2021; 134: 370–380.
46.
KotterJP. Leading change. Boston: Harvard Business Review Press, 2012.
47.
FrankSMSavageWJRothschildJA, et al.Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology2012; 117: 99–106.
48.
BarileLFominskyEDi TomassoN, et al.Acute normovolemic hemodilution reduces allogenic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials. Anesth Analg2017; 124: 743–752.
49.
HohnLSchweizerALickerM, et al.Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogenic blood transfusion requirements in cardiac surgery. Anesthesiology2002; 96: 276–282.
50.
ZhouZFJiaXPSunK, et al.Mild volume acute normovolemic hemodilution is associated with lower intraoperative transfusion and postoperative pulmonary infection in patients undergoing cardiac surgery—a retrospective, propensity matching study. BMC Anesthesiol2017; 17: 13.
51.
KarkoutiKCallumJWijeysunderaDN, et al.Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation2016; 134: 1152–1162.
52.
RaphaelJMazerCDSubramaniS, et al.Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. Anesth Analg2019; 129: 1209–1221.